Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P)

Corticosteroids are most commonly used to treat HTLV-1-associated myelopathy (HAM); however, their clinical efficacy has not been tested in randomized clinical trials. This randomized controlled trial included 8 and 30 HAM patients with rapidly and slowly progressing walking disabilities, respective...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamauchi, Junji, Tanabe, Kenichiro, Sato, Tomoo, Nakagawa, Masanori, Matsuura, Eiji, Tsuboi, Yoshio, Tamaki, Keiko, Sakima, Hirokuni, Ishihara, Satoshi, Ohta, Yuki, Matsumoto, Naoki, Kono, Kenichi, Yagishita, Naoko, Araya, Natsumi, Takahashi, Katsunori, Kunitomo, Yasuo, Nagasaka, Misako, Coler-Reilly, Ariella, Hasegawa, Yasuhiro, Araujo, Abelardo, Jacobson, Steven, Grassi, Maria Fernanda Rios, Galvão-Castro, Bernardo, Bland, Martin, Taylor, Graham P., Martin, Fabiola, Yamano, Yoshihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780460/
https://www.ncbi.nlm.nih.gov/pubmed/35062340
http://dx.doi.org/10.3390/v14010136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8780460/
https://www.ncbi.nlm.nih.gov/pubmed/35062340
http://dx.doi.org/10.3390/v14010136

Ejemplares similares